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Protocadherin LKC (PLKC) is a member of the heterogene-
ous subgroup of protocadherins that was identified and de-
scribed as a potential tumor-suppressor gene involved in con-
tact inhibition (Okazaki, N., Takahashi, N., Kojima, S., Masuho,
Y., and Koga, H. (2002) Carcinogenesis 23, 1139–1148 and Ose,
R., Yanagawa, T., Ikeda, S., Ohara, O., and Koga, H. (2009)Mol.
Oncol. 3, 54–66). Several aspects of the structure, posttrans-
lational processing, targeting, and function of this new pro-
tocadherin are still not known. Here, we demonstrate that the
expression of PLKCat the apicalmembrane domain and its con-
centration at regions of cell-cell contacts occur concomitantly
with significant elevation of PLKC-mRNA levels. Furthermore,
it can be found within the adherens junctions, but it does not
colocalize with tight junctions proteins ZO-1 and occludin,
respectively.Additionally, unlikeE-cadherin, PLKC is not redis-
tributed upon Ca2 removal. Biosynthetic labeling revealed N-
and O-glycosylation as posttranslational modifications as well
as a fast transport to the cell surface and a low turnover rate.
During differentiation, PLKC associates with detergent-resis-
tantmembranes that trigger its redistribution from intracellular
membranes to the cell surface. This association occurs concom-
itant with alterations in the glycosylation pattern.We propose a
role for PLKC in the establishment of a proper epithelial cell
polarity that requires O-linked glycosylation and association of
the protein with detergent-resistant membranes.
The establishment and maintenance of cell polarity is one of
the most important issues in a variety of tissues within organ-
isms from worms to humans. Achievement of tissue polarity is
linked to a distinct state of differentiation of each cell within the
monolayer. This differentiation occurs during cell proliferation
and development and is facilitated by cell-cell contacts and
extracellular stimulation via hormones, cytokines, or other
signals.
Themolecular mechanisms underlying cell differentiation
and formation of epithelial monolayers are highly conserved
among animals (3). During cell development, particular pro-
teins are targeted to the sites of cell-cell contacts to establish
strong connections with neighboring cells and form a closed
monolayer of cells that is capable of accomplishing barrier
functions.
In vertebrate cells several connective molecule families are
known to form zones of cell-cell contacts. The expression of
some of them is up-regulated (like several cadherins (4)), and
many proteins are redistributed to the sites of cell-cell contacts
(like zonula occludens protein 1 (ZO-1)2) during progression of
differentiation (5).
The cadherin superfamily has been long known to mediate
Ca2-dependent cell-cell adhesion in a homophilicmanner (6).
Cadherins are involved in several pivotal cellular functions,
such as recognition, signaling, and communication as well
as morphogenesis and angiogenesis (7–9). Various cadherins
mediate specific cell-cell adhesion and play a crucial role in the
formation and maintenance of tissues (10), particularly by
establishment of the adherent junction belt whereby they
bridge proteins to the actin cytoskeleton (11, 12).
A striking structural feature of cadherins is the unique extra-
cellular fragment that consists of multiple domains, the cad-
herin repeats, each comprising around 100 highly conserved
amino acid residues. Cadherins, such as E-cadherin, VE-, or
N-cadherin exhibit five extracellular repeats and show a high
similarity in their cytosolic domains (for review, see Ref. 13)
which interact with -catenins and small GTPases of the Rho
family and interfere in receptor-tyrosine kinase signaling (11,
14). Unlike cadherins, protocadherins form a heterogeneous
cadherin subgroup with a varying range of extracellular cad-
herin repeats (15, 16). Well known protocadherins are those
expressed in the nervous system (17, 18). However, protocad-
herins in other tissues have been also characterized, such as
-protocadherin (19), VE-cadherin-2 (20), or FAT-1 (21).
Some protocadherins function in embryonic development (22)
or gastrulation (23) andmay play a role in the development and
function of the nervous system (17, 18, 24, 25). In contrast to
cadherins, protocadherins reveal distinct structural features
that vary in the number of repeats (e.g. 4 in -protocadherin to
34 in FAT-1) and in their cytoplasmic tails, suggesting different
types of interactions with cellular components as well as func-
tional diversity.
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Amore recently described protocadherin is that expressed in
the liver, kidney, and colon (PLKC) (1, 2), which was later
renamed PCDH24 by the HUGO Nomenclature Committee.
Characteristics of PLKC are seven extracellular cadherin
repeats with 93–117 amino acids each and a 35-amino acid-
long cytoplasmic domain that is terminated by a PDZ binding
domain. An interaction with the PDZ domain of hMAST205
has been demonstrated, suggesting a possible role as a switch
for intracellular signaling (1). The aimof this studywas to inves-
tigate the structural features of PLKC, its biosynthesis, intracel-
lular processing, and sorting during differentiation.
EXPERIMENTAL PROCEDURES
Materials and Reagents—Streptomycin, penicillin, gluta-
mine, Dulbecco’s modified Eagle’s medium, methionine-free
Dulbecco’s modified Eagle’s medium, fetal calf serum, and
trypsinwere purchased fromPAALaboratoriesGmbH (Pasch-
ing, Austria). Pepstatin, leupeptin, aprotinin, trypsin inhibi-
tor, and molecular mass standards for SDS-PAGE were from
Sigma. Soybean trypsin inhibitor was obtained from Roche
Diagnostics.
L-[35S]Methionine (1000Ci/mmol), Alkophos direct labeling
of DNA probes kit, Hybond N nylonmembranes, and protein
A-Sepharose were obtained from Amersham Biosciences.
Acrylamide, N,N-methylenebisacrylamide, and N,N,N,N-
tetramethylethylenediamine were purchased from Carl Roth
GmbH (Karlsruhe, Germany). SDS, ammonium persulfate,
dithiothreitol, and Triton X-100 were obtained fromMerck.
The pEYFP-N1 vector was purchased from Clontech Labora-
tories Inc. (Heidelberg, Germany). Immunoprecipitation and
Western blotting of PLKC-YFP were performed with anti-GFP
antibody (BDTransduction Laboratories). For immunofluores-
cence studies, anti-ZO-1 and anti-occludin (Zymed Laborato-
ries Inc., San Francisco) and anti-E-cadherin (BDTransduction
Laboratories) were used. Phalloidin-ALEXAFluor 546 for actin
staining and Alexa Fluor 568 anti mouse were purchased from
Invitrogen. Commercial monoclonal antibody against flotil-
lin-2 and RhoA were from Santa Cruz Biotechnology (Heidel-
berg, Germany).
RNA Isolation, Reverse Transcriptase-PCR, and Competitive
PCR—RNA was isolated from cells using the RNeasymini kit
from Qiagen (Hilden, Germany) according to the manufactur-
er’s instructions. The cDNA was synthesized by using the First
Strand cDNA Synthesis kit (MBI Fermentas, St. Leon-Rot,
Germany) with random hexamer nucleotide primers. PCR
was performed on a Biometra Personal Cycler (Biometra,
Go¨ttingen, Germany) using the following primers: PLKC for-
ward (5-CAGCGGGCTCAGCCTCCGTTC-3) and PLKC
reverse (5-CTGTCCAGGGGCCCCAGGTTTCTG-3) or -
actin forward (5-GGCATCGTGATGGACTCCG-3) and
-actin reverse 5-GCTGGAAGGTGGACAGCGA-3, respec-
tively. Intensity of the DNA bands was assessed in a charged
coupled device (CCD) camera and quantified using Quantity
One 4.5.2 software (both are products of Bio-Rad). The max-
imum expression of PLKC in fully differentiated and polar-
ized cells was set as 100%, and other samples were quantified
accordingly.
Northern blot analysis of RNA from subconfluent and
confluent MDCK cells was performed on nylon membranes
according to Sambrook et al. (26) using a 32P-labeled DNA
probe corresponding to a fragment of the PLKC cDNA (1–
1700 bp). The nylon membrane was exposed overnight to
x-ray film (Eastman Kodak Co.). The quantitative analysis of
the labeling intensities of the RNA transcripts was further
determined using Fluor S multiimager specific programs
(Bio-Rad).
Expression Vectors—To generate a YFP-tagged version of
PLKC, an expression vector was generated using the following
primers: PLKC forward (5-GAATTCGATGGCCCAGCTAT-
GGCTGTC-3) and PLKC reverse (5-CCGCGGTGACAG-
GTCCGTGGT-3). The resulting expression vector pEYFP-
PLKC contained enhanced YFP fused in-frame to the 3 end of
PLKC.
Transfection and Generation of Stable Cell Lines—MDCK-II
cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum, 2 mM glutamine, 50
units/ml penicillin, and 50mg/ml streptomycin at 37 °C in a 5%
CO2 atmosphere. The cells were transfected with 5 g of the
appropriate recombinant DNA using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. Sta-
bly transfected cell lines were selected in the presence of 0.25
mg/ml active G418 (Invitrogen), and after 18–23 days, surviv-
ing colonies were isolated. Stable cells expressing PLKC-YFP
were screened by immunoprecipitation and by fluorescence
laser confocal microscopy. The generated clones were indi-
cated MDCK-PLKC-YFP. For co-localization studies MDCK-
PLKC-YFP cells were transiently transfected with Golgi-dsRed
cDNA (Clontech) using Lipofectamine (Invitrogen) following
the manufacturer’s instructions.
Biosynthetic Labeling, Immunoprecipitation, and Immuno-
blotting—Cells were incubated in methionine-free minimum
Eagle’s medium for 2 h before labeling in the same medium
containing 50 Ci of [35S]methionine for the indicated time
intervals. In pulse-chase experiments the cells were labeled
with [35S]methionine for the indicated times and chased with
methionine-containing standard culture medium for different
periods of time. Cell solubilization and immunoprecipitation of
GFP-tagged PLKC molecules were performed according to
established procedures (27) using anti-GFP antibodies. The
immunoprecipitated proteins were further analyzed by SDS-
PAGE. The radioactive protein bands were visualized using a
phosphorimaging device (Bio-Rad. In some experiments
N-linked deglycosylation of the precipitated proteins was per-
formed with endoglycosidase H or endoglycosidase F/PNGase
F (Roche Diagnostics) according to themanufacturer’s instruc-
tions. Western blotting was performed using anti-GFP anti-
body at a dilution of 1:1000. The secondary antibody employed
anti-mouse antibody conjugated to horseradish peroxidase
(Amersham Biosciences), and the protein bands were visual-
ized by enhanced chemiluminescence using SuperSignal
ELISAFemtoMaximumSensitivity Substrate fromPierce accord-
ing to the manufacturer’s instructions. Detection occurred by the
ChemiDoc system together with the QuantityOne software (both
fromBio-Rad) and x-ray (x-ray RetinaXBA) film sheets (Fotoche-
mischeWerke GmbH Berlin, Germany).
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Detergent-resistant Membrane (DRM) Extraction—Associ-
ation of PLKC with DRMs was investigated by a discontinuous
sucrose-density gradient as reported previously (28). In brief,
cells at a subconfluent stage of differentiation (around 50%
optical confluence) and 2 days after confluence were lysed with
1% (w/v) of Triton X-100 in PBS. After low speed centrifuga-
tion, each samplewas diluted to a final sucrose concentration of
40% and laid onto an 80% sucrose cushion. Then 1ml of sample
was overlaid with 7ml of 30% sucrose and 1ml of 5% sucrose on
the top and, finally, centrifuged for 18 h at 100,000  g with a
swing-out rotor. Nine fractions of 1 ml each were collected
from the top and analyzed for the protein content by Western
blotting. The distribution of the marker proteins flotillin-2 and
RhoA was tested as the positive and negative control,
respectively.
Immunofluorescence and Confocal Laser Scanning Micro-
scopy—Cells grown on coverslips were fixed with 4% paraform-
aldehyde in PBS for 45 min at room temperature. For imaging
of intracellular and surface-localized proteins, the cells were
treated with 0.5% saponin in 1% bovine serum albumin-PBS.
Primary antibodies were used at the following dilutions in PBS
(v/v): anti ZO-1 (1:100), anti-occludin (1:100), and anti-E-cad-
herin (1:50). The secondary antibodies employed Cy3 anti-rab-
bit (Sigma) and Alexa Fluor 568 anti-mouse (Invitrogen) at a
dilution of 1:1000. Confocal laser scanning microscopy of
living or fixed cells was performed in a Leica TCS SP2 micro-
scope with a 63 water planapochromat lens (Leica Micro-
systems, Mannheim, Germany). Dual color YFP and Cy3 or
Alexa Fluor images were obtained
by sequential scanswith the 468-nm
excitation line of an argon laser or
the 543-nm excitation line of a
He/Ne laser, respectively, and the
optimal emission wave length for
GFP or Cy3/Alexa.
Treatment of CellMembrane Pro-
teins with Trypsin—Stably trans-
fected MDCK cells were labeled
with 50 Ci of [35S]methionine for
8 h, washed twice with ice-cold PBS,
and incubated with 100 g tryp-
sin/ml in PBS on ice for 45 min.
After quenching excess trypsin with
200 g of soybean trypsin, inhibitor
cells were processed for immuno-
precipitation as described above.
Inhibition of Glycosylation and
Depletion of Cholesterol—To test
the role of glycosylation on the sort-
ing of PLKC, inhibitors of glycosy-
lation processing were added to
the growth medium during 24 h
of cell culture. Benzyl-GalNAc
(4 mM) was used as an inhibitor of
O-glycosylation and deoxyman-
nojirimycin (DMM) (5mM) was uti-
lized to interfere with processing of
N-glycosylated PLKC. For choles-
terol depletion, methyl--cyclodextrin was used at 50 mM final
concentration. All inhibitors were obtained from Sigma.
RESULTS
Expression and Subcellular Distribution of PLKC—The sub-
cellular distribution and intracellular processing of PLKC were
analyzed using PLKC fused at its C-terminal end to YFP. This
chimeric protein was stably expressed inMDCK-II cells, which
are denoted thereafter as MDCK-PLKC-YFP.We used this cell
line rather than wild type MDCK cells to investigate the struc-
ture and function of PLKC for twomain reasons. First, the lim-
ited access to anti-PLKC antibodies hampered these analyses,
whereas the recombinant PLKC-YFP protein could be analyzed
using commercially available anti-GFP antibodies that recog-
nize the YFP variant of GFP. Second, wild type endogenous
PLKC showed a similar cellular distribution as PLKC-YFP as
assessed by anti-PLKC antibodies (1).
We first analyzed the cellular localization of PLKC-YFP in
differentiatingMDCKcells. Fig. 1 reveals a striking alteration in
the protein distribution pattern of PLKC at the plasma mem-
brane. In single MDCK-II cells (Fig. 1A, single) PLKC accumu-
lates intracellularly, mainly in the Golgi apparatus (white
arrow) as confirmed by colocalization of PLKC-YFP with a
Golgi-dsRed marker that was transiently co-expressed in these
cells (Fig. 1B).
Furthermore, PLKC-YFP appears also in single cells as fila-
mentous structures at the cell surface (blue arrow). Readily
upon first contacts with neighboring cells, PLKC protein mol-
FIGURE 1.PLKCexpression is affectedby cell-cell contacts inMDCK-II.A, MDCK-PLKC-YFP cells were plated
at low density, and subcellular distribution was analyzed using confocal laser microscopy during formation of
a confluent monolayer. Blue arrow, cell surface; white arrow, Golgi apparatus; red arrow, cell-cell contact sites.
B, shown is confocal lasermicroscopy ofMDCK-PLKC-YFP cells transiently transfectedwith cDNAGolgi-dsRed.
C, mRNA samples from MDCK-II cells of distinct stages of differentiation were estimated for expression of
PLKC-mRNA by semiquantitative PCR. For quantification purposes the -actin mRNA levels were used.
D, Northern blot analysis is shown of polar and non-polar MDCK-II cells including 28 S and 18 S RNA controls.
Scale bar, 10 m.
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ecules are sorted toward the cell-cell contact sites (Fig. 1A,
islands). Finally in a fully differentiated monolayer at 5 days
postconfluence, nearly the entire protein is directed to the cell-
cell contacts or localizes at the apical membrane (Fig. 1A, con-
fluent), whereas the basal cell surface is totally devoid of PLKC
(data not shown). Remarkably, all the cells examined exhibited
high expression levels of PLKC molecules in cell membrane
protrusions, particularly in cell-cell contact areas.
Transcriptional Analysis of PLKC-YFP in MDCK Cells—
Concomitant with differentiation, the expression of PLKC
mRNA increases substantially as assessed by semiquantitative
PCR (Fig. 1C). In fact, the mRNA levels increase steadily and
strikingly when comparing cells revealing random membrane
and intracellular distribution of PLKC (left two lanes, single and
islands) with their fully differentiated epithelial counterparts
(right two lanes, confluent and postconfluent). Additionally,
RNA frompolarized, differentiated (confluent), and non-polar-
ized (20% confluent) MDCK cells were analyzed by Northern
blot analysis (Fig. 1D). The quantitative analysis of the labeling
intensities in both polar and non-polar cells was evaluated rel-
ative to the labeling intensities of the ribosomal RNA before
blotting, and the results revealed an almost 7-fold higher
expression of the PLKC gene in polarized MDCK cells com-
pared with the non-polarized ones.
PLKC Is Colocalized with E-cadherin in the Adherens Junc-
tions but Is Not Present in Zonula Occludens—We next exam-
ined the subcellular distribution of PLKCat the cell-cell contact
regions of the lateral side in epithelial cells.
PLKC colocalizes with E-cad-
herin at sites of lateral cell-cell con-
tacts (Fig. 2, A and B), but not with
ZO-1 and occludin (Fig. 2,C andD),
two protein markers of the zo-
nula occludens belt complex in
polarized epithelial monolayers
(5, 29). Both tight junction pro-
teins are expressed in limited
regions at the most apical cell-cell
contacts (blue arrow), but their
localization is clearly distinct from
spots of PLKC, which never colo-
calized with ZO-1 or occludin.
Interestingly, the strongest PLKC
expression was found at the apical
membrane (white arrow).
Membrane Localization of PLKC
Is Not Affected by Calcium Deple-
tion—Calcium concentration plays
a crucial role in establishment and
maintenance of epithelial monolay-
ers. In fact, chelation of extracellular
calcium ions disrupts the adherens
junctions with subsequent dramatic
alteration in the distribution of
E-cadherin and other cadherins as
well as cell detachment (30, 31).
We investigated, therefore, the
impact of extracellular calcium on
the subcellular distribution and cell surface expression of PLKC
by calcium depletion in a time-course experiment utilizing the
calcium specific chelating reagent EGTA. The positive control
employed E-cadherin that is normally affected by calcium.
Fig. 3A shows that the addition of EGTA to MDCK-PLKC-
YFP cells did not affect the cell surface localization of PLKC,
whereas a substantial redistribution of E-cadherin from the cell
membrane to submembranous and vesicular structures oc-
curred (compare Fig. 3A ( EGTA) with Fig. 2A ( EGTA)).
No change in the distribution patterns of these two proteins
was observed with increasing time until cell detachment
occurred after45 min. Here, nearly all E-cadherin molecules
accumulated in the cell body, whereas PLKC persisted at the
plasmamembrane regardless of calcium removal. Interestingly,
after 30 min most cells lost their intercellular contacts and
adopted a rounded shape butmaintained their adherence to the
plates via a filamentous network in basal cell protrusions that
exhibited a high expression of PLKC-YFP (Fig. 3B). The effect
of calcium depletion was reversible.
Biosynthesis, Processing, and Cell Surface Expression of PLKC—
We next investigated the biosynthesis and processing of PLKC
in differentiatedMDCK-PLKC-YFP as well as its delivery to the
cell surface. Fig. 4, A and B, shows that the earliest detectable
biosynthetic form of PLKC-YFP is the ER-resident, endo
H-sensitive 170-kDa mannose-rich polypeptide (PLKCh) that
shifts to 145 kDa after endo H treatment. Further processing in
the Golgi apparatus generates the endo H-resistant complex-
glycosylated 210-kDa mature form of PLKC (PLKCC), which
FIGURE 2. PLKC is targeted in epithelial cells to the adherens but not to the tight junctions.MDCK-PLKC-
YFP cells were grown to confluence and fixed with paraformaldehyde. Cells were permeabilized with 0.5%
saponin. A, E-cadherin was stained with anti-E-cadherin antibody. An Alexa Fluor 568 conjugate was used as
secondary antibody. B, shown is an xz-section scan ofMDCK-PLKC-YFP cells stained for E-cadherin. C, ZO-1 and
occludin were labeled in MDCK-PLKC-YFP cells using a Cy3-conjugated secondary antibody. D, shown is an
xz-section scan of MDCK-PLKC-YFP (green) cells stained for occludin (red). Cell integrity was confirmed by DNA
staining (blue). Scale bar, 10 m.
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shifts uponN-deglycosylationwith PNGase F generating a 160-
kDa protein (Fig. 4A, third lane). Similar to endo H treatment,
PNGase F shifted the mannose-rich polypeptide also to a 145-
kDa protein. The difference between the two PNGase products
could, therefore, be attributed to the presence of O-glycans on
PLKC.
Another issue we addressed was the rate of maturation and
trafficking of PLKCusing pulse-chase experiments. EndoHwas
used to distinguish between early ERmannose-rich andmature
processed complex-glycosylated forms of PLKC. Fig. 4B shows
that PLKC is transported from the ER to theGolgi at a rapid rate
as assessed by the appearance of endo H-resistant PLKC forms
already after 15 min of chase.
The trafficking of mature PLKC to the cell surface was
probed by treatment of intact cells with trypsin. Trypsin was
demonstrated in preliminary experiments to cleave PLKC and
is, therefore, expected to cleave cell surface exposed PLKCmol-
ecules (not shown). As shown in Fig. 4C this treatment gener-
ated a cleaved form of PLKC already at 30 min of chase after
complex glycosylation of PLKC in the Golgi occurred. The
intensity of the truncated PLKC form increased at 1 h of chase
with a concomitant decrease in that of uncleaved PLKCC; the
intracellular mannose-rich form PLKCh remained unaffected.
This result points to a precursor-product relationship between
PLKCC and the cleaved form and indicates that PLKCC is
exposed at the cell surface. The data further support the notion
that PLKC transport to the cell surface occurs rapidly and at
almost similar rates to its transport between the ER and the
Golgi. In fact, truncated surface-exposed PLKCC (30 min of
chase) occurs 15min after complex glycosylation, which in turn
also occurs after 15 min of chase. Moreover, PLKC has a very
slow turnover rate (Fig. 4D).
PLKC Associates with Lipid Rafts during Differentiation of
MDCK Cells—The altered cellular localization of PLKC from
intracellular compartments in non-polarized cells to sites of
cell-cell contacts and to the apical membrane raises questions
regarding potential mechanisms implicated in this redistribu-
tion. This is particularly interesting in light of the unique and
predominant localization of this protocadherin at the apical
membrane. One potential sorting mechanism in epithelial cells
implicates the association of proteins with specialized mem-
brane microdomains that are resistant to solubilization in the
cold with non-ionic detergents (for review, see Refs. 32 and 33).
Thesemicrodomains, also referred to asDRMsor lipid rafts, are
enriched in cholesterol and sphingolipids whenTritonX-100 is
used as the discriminating detergent. We, therefore, asked
whether PLKC associates with DRMs along the secretory path-
way with particular emphasis on the temporal requirements of
this association. Triton X-100 cell extracts of MDCK-PLKC-
YFP at subconfluent stage of differentiation and 2days postcon-
fluencewere subjected to sucrose gradients, and the presence of
PLKC was examined in the floating fractions. Fig. 5 shows that
PLKC was entirely recovered from the Triton X-100-soluble
fractions in subconfluent MDCK cells (Fig. 5A). By contrast,
analysis of confluent MDCK-PLKC-YFP cells, in which PLKC
was exclusively expressed at the cell surface, revealed a shift in
the pattern of PLKC toward the Triton X-100-insoluble float-
ing fractions (Fig. 5B). The distribution pattern for flotillin, a
protein that is often used as a marker of DRMs, differed from
that of PLKC. Here, flotillin bands were detected in the floating
fractions of the lysates of subconfluent aswell as confluent cells.
RhoA, a marker of proteins that are not associated with DRMs,
was recovered in the soluble fractions regardless of cell conflu-
ency. The differing band pattern of PLKC in the floating frac-
tions as compared with that in the soluble fractions suggests at
first glance qualitative differences between the two forms con-
comitant with different subpopulations of PLKC in the floating
and soluble fractions. The finding that PLKC redistributes from
intracellular sites to the cell surface, particularly to the apical
membrane, concomitant with its association with DRMs, is
indicative of an essential role of these microdomains in the
trafficking and cell surface delivery of PLKC during cellular
differentiation.
Influence of O-Glycosylation on PLKC Sorting—It has been
previously shown that a potential sorting mechanism of mem-
brane glycoproteins to the apical membrane utilizes O-glycans
as a sorting signal in association with DRMs (34–38). We,
therefore, tested if the glycosylation of PLKC is altered in dif-
ferentiated and undifferentiated MDCK-PLKC-YFP. Fig. 6A
shows a Western blot analysis of PLKC in total cell lysates
extracted from subconfluent and 2 days confluent cells.
FIGURE 3. E-cadherin, but not PLKC, is redistributed upon calcium
removal. MDCK-PLKC-YFP cells were grown until 5 days after confluence.
Thereafter, calciumwas chelated by the addition of EGTA (5mM final concen-
tration). Samples were fixed at different time points (the 10min time point is
shown inA). For visualization of E-cadherin, cells were processed by immuno-
fluorescence as described above. In B, subcellular localization of PLKC after 30
minof incubationwithEGTAwasvisualizedbydifferential section scanning.A
basal cell protrusion is indicated by awhite arrow. Scale bar, 10 m.
Structural Features and Biosynthesis of PLKC
APRIL 23, 2010•VOLUME 285•NUMBER 17 JOURNAL OF BIOLOGICAL CHEMISTRY 13197
 by guest on July 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Although a difference in the size of PLKC in the subconflu-
ent and confluent and fully differentiated cells is not clearly
seen, treatment with PNGase F reveals a slight, but definite
increase in the digested form of PLKC in differentiated cells
in comparison to the subconfluent cells. Because PNGase F
digests N-linked but not O-linked glycans, we propose that the
elevated size of PLKC in differentiated cells is due to an
increased content ofO-glycans in these cells. To assess the role
of O-glycosylation in the association of PLKC with DRMs, we
utilized benzyl-N-acetylgalactosamine (BNG) that interferes
and inhibits O-glycosylation. First, we examined the inhibi-
tory capacity of BNG on the O-glycosylation of PLKC by
comparing the electrophoretic mobilities of PLKC before
and after treatment with BNG. Fig. 6B shows that BNG has
reduced the size of PLKC, supporting the notion that PLKC
and PNGase F digestion generates a smaller protein product
from this glycoform as compared with PLKC from BNG-
non-treated cells. These results support the notion that the
O-glycosylation of PLKC has been inhibited or substantially
affected in the presence of BNG. We next investigated the
relevance ofO-glycosylation to the association of PLKC with
DRMs by assessment of the presence of BNG-affected PLKC
in the floating fractions of Triton X-100 cell extracts of
BNG-treated cells. Fig. 6C reveals that PLKC was not
detected in the floating fraction, whereas the DRM marker
flotillin was clearly found in these fractions. Therefore,
O-glycosylation is necessary for the association of PLKC
with DRMs, and an alteration in the content of O-glycosyla-
tion, for instance during cellular differentiation, redistrib-
utes PLKC from the Triton X-100-insoluble DRMs to the
soluble fractions. On the other hand, inhibition of N-glyco-
sylation by DMM did not exclude PLKC completely from
detergent-resistant membranes (Fig. 6D).
To further investigate the role of O-glycosylation in the
trafficking of PLKC, we examined its localization on the cell
surface in the presence of BNG, i.e. after inhibition of O-gly-
cosylation. Fig. 7 shows that PLKC is distributed on both
sides of the membrane in the presence of BNG, supporting
the view that O-glycosylation is implicated in polarized traf-
ficking of PLKC. DMM, by contrast, did not alter the subcel-
lular localization of PLKC in comparison to untreated con-
trol. As shown above, PLKC associates with DRMs during
FIGURE 4. Biosynthesis of PLKC. A, MDCK-II cells stably expressing PLKC-YFP were labeled with [35S]methionine for 6 h, and the detergent extracts were
processed by immunoprecipitation with anti-GFP antibody. Immunoprecipitates were treated with endo H or PNGase F before SDS-PAGE on 5% slab-gels. In
pulse-chase experiments, MDCK-PLKC-YFP cells were labeled for 15 min (B and C) or 2.5 h (D) with [35S]methionine and subsequently chased with nonradio-
active culture medium for the indicated time intervals. Thereafter, PLKC-YFP was immunoprecipitated from the detergent extracts of the cells with anti-GFP
antibodies. Where indicated, intact cells were treated with 100 g trypsin/ml in PBS for 45 min on ice before cell lysis.
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cellular differentiation. We examined whether DRMs are
required for PLKC-polarized trafficking and treated MDCK-
PLKC-YFP cells with cyclodextrin, an inhibitor of choles-
terol. Confocal images in Fig. 7 reveal a dramatic change in
the pattern of PLKC and a shift to non-polarized cellular
distribution.
DISCUSSION
The subcellular localization of PLKC depends strongly on
the differentiation state of epithelial cells as it redistributes
from a predominant intracellular localization in non-polar-
ized cells to sites of cell-cell contacts during polarization. In
addition to this localization, a substantial proportion of PLKC is
also located at the apical domain of polarizedMDCK cells, ren-
dering PLKCunique amongother cadherins (39, 40). The apical
localization is presumably mediated by a putative PDZ binding
domain that is present in the cytosolic tail of PLKC. Impor-
tantly, the subcellular distribution of PLKC is linked to its asso-
ciation with DRMs during differentiation of MDCK and acqui-
sition of polarized morphology. Thus, in non-confluent or
subconfluent cells PLKC accumulates mostly intracellularly
and is not associated with DRMs. On the other hand, a major
proportion of the protein becomes associatedwithDRMs and is
trafficked to the apical membrane when the cells acquire a
polarizedmorphology. Our data strongly suggest that the puta-
tivemechanism responsible for this alteredmode of association
depends on the pattern of O-glycosylation of PLKC during dif-
ferentiation. In fact,O-glycosylation of PLKC slightly increases
during differentiation of MDCK cells, and inhibition of this
type of glycosylation with BNG results in a complete redistri-
bution of PLKC from DRMs to the Triton X-100-soluble frac-
tions. It is, therefore, likely that O-glycans could act as a target
signal that interacts with a potential sorting receptor with sub-
sequent recruitment of PLKC to DRMs. It has been previously
shown that a potential sorting
mechanism of membrane glycopro-
teins to the apical membrane uti-
lizes O-glycans as a sorting signal in
association with DRMs (34–38).
The molecular basis of this putative
sorting mechanism is still unre-
solved. Nevertheless, the discrimi-
nation between PLKC molecules in
MDCK cells based on their associa-
tion with DRMs and elevatedO-gly-
cans provides an invaluable and
promising model system that could
be utilized to address this mecha-
nismat themolecular level. Another
feature of PLKC that is presumably
linked to its association with DRMs
is its persistence at the cell surface
upon depletion of extracellular cal-
cium and subsequent disruption
of cell-cell contacts. This feature
clearly distinguishes PLKC from
cadherins, which are usually redis-
tributed to submembranous com-
partments under similar conditions
(41). Cadherins are predominantly
localized at the sites of cell-cell con-
FIGURE 5. PLKC associates with DRMs during differentiation. Two-day
confluent (A) or subconfluent (50%) (B) cells were lysed with 1% (w/v) of
TritonX-100 in PBS. After low speed centrifugation, the samplewas diluted to
a final sucrose concentration of 40% and laid onto an 80% sucrose cushion.
The 1-ml sample was then overlaid with 7 ml of 30% sucrose and 1 ml of 5%
sucrose on the top and finally centrifuged for 18 h at 100,000  g with a
swing-out rotor. Nine fractions of 1 ml each were collected from the top and
analyzed for the protein content by immunoblotting. The distribution of the
marker proteins flotillin-2 and RhoAwas tested as positive and negative con-
trol, respectively. subconf, subconfluent.
FIGURE 6. Influence ofO-glycosylation onPLKCdifferentiation.A, 2-day confluent or subconfluent (50%)
MDCK-PLKC-YFP were lysed, and proteins were precipitated, treated with PNGase F or not treated, separated
via SDS-PAGE, and visualizedby immunoblotting.B, confluentMDCK-PLKC-YFP cellswere treatedwith BNG for
24 h or not treated. Subsequently, cells were lysed, and proteins were precipitated, treated with PNGase F or
not treated, separatedvia SDS-PAGE, andvisualizedby immunoblotting.C, confluent cellswere treated for 24h
with BNG and thereafter lysedwith 1% (w/v) of Triton X-100 in PBS. After low speed centrifugation, the sample
wasdiluted to a final sucrose concentrationof 40%and laid onto an80%sucrose cushion. The 1-ml samplewas
then overlaid with 7 ml of 30% sucrose and 1 ml of 5% sucrose on the top and finally centrifuged for 18 h at
100,000gwitha swing-out rotor.Nine fractionsof 1ml eachwere collected fromthe topandanalyzed for the
protein content by immunoblotting. sub, subconfluent; conf, confluent. D, the experimental setup was the
same as described in C, but the cells were treated with DMM instead of BNG.
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tacts and are not associated with DRMs. It is tempting to spec-
ulate that PLKC clustered into DRMs does not require calcium
ions for its stability and retains its cellular localization inde-
pendent of calcium. The data presented here unequivocally
demonstrate that the expression of PLKC at the mRNA level is
significantly up-regulated when cell-cell contacts occur and
reaches itsmaximum in polarizedmonolayers several days after
confluence.
Finally, DRMs have been shown to serve as platforms for
signaling pathways, and it is possible that DRMs-associated
PLKC may trigger downstream signaling cascades that ulti-
mately regulate essential components of the tight junctions,
such as claudins and occludins. Pece and Gutkind (42) report
that E-cadherin is capable of inducing mitogen-activated pro-
tein kinase pathway signaling by a ligand-independent activa-
tion of the epidermal growth factor receptor. A correlation
between overexpression of E-cadherin and its tight junction
barrier function has not been yet established. It is, therefore,
tempting to speculate that even the permeability of renal corti-
cal ducts can be modulated by different expression levels of
cell-adhesion molecules, not only tight junction proteins, but
also members of the cadherin family. Because more evidence is
provided that the latter are capable of mediating intracellular
signaling pathways, a dynamic and rapid regulation of the tight-
ness of the intercellular barrier upon extracellular signal activa-
tion can be proposed. One step further is the assumption that
PLKC might serve as a potential receptor by virtue of its local-
ization at the apical membrane and, thus, its exposure to
intraluminal signals. Altogether, we conclude that PLKCmod-
ulates cell polarity and structural properties of epithelial cells
presumably upon induction of adhesive cell-cell contacts. This
modulation depends on the interaction of PLKC with DRMs
that occurs during cellular differentiation in MDCK cells.
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FIGURE 7. Subcellular distribution of PLKC changes after cholesterol
depletion or BNG treatment but is independent of N-glycosylation.
MDCK-PLKC-YFP cells were plated on coverslips, and subcellular distribution
was analyzed using confocal laser microscopy after treatment with BNG,
DMM, or methyl--cyclodextrin (Cyclo D).
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